Organotics
PrivateCompany Overview
Organotics is a biotechnology company that uses AI and patient-derived brain models to fast-track personalized medicine for conditions like autism, schizophrenia, and Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share
AI Layer
Application
Keywords
brain organoidsmulti-region brain organoidsMRBOsAI drug discoverydrug discovery platformpreclinical drug screeningCNS drug discoveryTechBiobiomarker discoverytarget identificationpatient-derived modelscomputational genomicsorganoid intelligencebiocomputingbrain-on-a-chippharmaceutical partnerships
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Organotics Comparables
Compare Organotics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Herophilus | 87% | |
| OrganoTherapeutics SARL | 84% | |
| Vivodyne | 83% | |
Organotics Funding Rounds
Historical fundraising activity
Organotics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Organotics's valuation, stock price, and market status.
See something wrong or outdated?